Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Department for Business Energy and Industrial Strategy
1 Victoria Street, Westminster
London
SW1H 0ET
UK
Person cyswllt: VTF Commercial Team
Ffôn: +44 2072155000
E-bost: VTFContracts@beis.gov.uk
NUTS: UKI
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy
I.4) Y math o awdurdod contractio
Gweinyddiaeth neu unrhyw awdurdod cenedlaethol neu ffederal arall, gan gynnwys eu his-adrannau rhanbarthol neu leol
I.5) Prif weithgaredd
Gwasanaethau cyhoeddus cyffredinol
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Supply Agreement for AZD1222
Cyfeirnod: 2577/08/2020
II.1.2) Prif god CPV
33651600
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
Procurement of the AZD1222 vaccine.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 1.00 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKH12
Prif safle neu fan cyflawni:
Cambridgeshire CC.
II.2.4) Disgrifiad o’r caffaeliad
Procurement of the AZD1222 vaccine.
II.2.5) Meini prawf dyfarnu
Price
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
II.2.14) Gwybodaeth ychwanegol
Contract value is being withheld due to commercial sensitivity (Reg 50(6)(b) and (c)). Publication may enable competitors to calculate cost per dose. This will commercially prejudice:
(i) the supplier in its negotiations with other national governments; and
(ii) the contracting authority in negotiations with other vaccine vendors.
It may also impact fair competition between vaccine vendors.
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Brys eithafol yn sgil digwyddiadau nad oedd modd i’r awdurdod contractio eu rhagweld ac yn unol â’r amodau llym a nodir yn y gyfarwyddeb
Esboniad
The award of the contract to AZ is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)). In addition competition was absent from any competed procurement because AZ has exclusive rights to the vaccine being developed by Oxford University (Reg 32(2)(b)(iii)).
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
Section V: Dyfarnu contract
Rhif Contract: 2577/08/2020
Teitl: Supply Agreement for AZD1222
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
28/08/2020
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Nifer y tendrau a ddaeth i law gan BBaChau: 0
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau yr UE: 0
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau nad ydynt yn aelodau o'r UE: 0
Nifer y tendrau a ddaeth i law drwy ddulliau electronig: 0
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
AstraZeneca UK Ltd
03674842
1 Francis Crick Avenue, Cambridge Biomedical Campus
Cambridge
CB2 0AA
UK
NUTS: UKH12
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 1.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
Contract end date is being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)) and commercial sensitivity (Reg 50(6)(b) and (c)). The date is variable based on production and delivery. Given significant challenges to overcome, the end date may set unrealistic expectation for the public/market. Also, given significant competition to bring to the market a successful vaccine, provision of the contract term is valuable information to competitors that may impact negotiations/ future competition.
Sub-contractor details are being withheld on grounds that release would be contrary to public interest (Reg 50(6)(a)). This is very sensitive given potential for targeting and disruption of the activities at facilities which are critical to success and delivery of contract.
To view this notice, please click here: https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=528915924
Go reference: GO-2020930-PRO-17154323
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
Department of Business, Energy and Industrial Strategy
1 Victoria Street, Westminister
London
SW1H 0ET
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
30/09/2020